B
Biocentis
Genetic insect control solutions for agriculture and health
About Biocentis
Biocentis is a forward-thinking biotech company focused on pioneering innovative solutions in the realm of biological control. With a mission to create sustainable and environmentally friendly alternatives to traditional pest management, Biocentis harnesses the power of advanced biotechnologies to address some of the most pressing challenges in agriculture and public health.
Read full description
At the core of Biocentis' work is the development of cutting-edge biological control agents. These agents, derived from natural organisms, are designed to target and manage pest populations in a way that minimizes ecological disruption and promotes biodiversity. By leveraging the latest advancements in genetic engineering, microbiology, and molecular biology, Biocentis creates highly specific and effective biocontrol solutions that offer a safer alternative to chemical pesticides.
Biocentis' product portfolio includes a range of innovative biocontrol agents tailored to various applications. These products are rigorously tested to ensure their safety, efficacy, and environmental compatibility. By integrating these biocontrol agents into pest management strategies, Biocentis helps farmers, public health officials, and other stakeholders reduce their reliance on harmful chemicals and move towards more sustainable practices.
Collaboration and research are fundamental to Biocentis' approach. The company partners with leading research institutions, industry experts, and regulatory bodies to ensure that its solutions are based on the latest scientific knowledge and adhere to the highest standards of safety and efficacy. This collaborative spirit also extends to engaging with local communities and stakeholders to understand their needs and develop tailored solutions that address specific pest management challenges.
Biocentis is committed to ongoing innovation and the continuous improvement of its products and processes. The company invests heavily in research and development, exploring new technologies and methodologies to enhance the performance and sustainability of its biocontrol agents. This commitment to innovation positions Biocentis at the forefront of the biological control industry, driving forward the transition to more sustainable and environmentally responsible pest management practices.
In addition to its focus on product development, Biocentis places a strong emphasis on education and advocacy. The company actively works to raise awareness about the benefits of biological control and the importance of sustainable pest management. Through outreach programs, educational initiatives, and partnerships with advocacy groups, Biocentis seeks to inspire a broader movement towards more eco-friendly agricultural and public health practices.
Ultimately, Biocentis aims to transform the way we approach pest management, offering innovative, effective, and sustainable solutions that protect both human health and the environment. By championing the use of biological control agents and promoting a shift towards more sustainable practices, Biocentis is helping to build a healthier, more resilient future for our planet.
At a glance
- Status
- Operational
- Founded
- 2021
- Headquarters
- London, United Kingdom
- Employees
- 25
- Open positions
- None listed
- Dealroom signal
- 88.7/100
- Industry
- Health
- Sub-industry
- BioTechnology, AgriTech
- Sector
- Biotech & Life Sciences, Biotechnology, Crop Protection, Infections and Infectious Diseases, Pest Control, Spinout, Sustainable Development Goals, Regenerative Agriculture, Climate Tech
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANT✓Other financing | Nov 2025 | $6M | — | Wellcome Trust | ↗ |
| SEED✓Equity / VC | Nov 2025 | $13M | $52M | Grantham Foundation · Algebris Investments | ↗ |
Growth signals
Latest recorded traffic for Biocentis is 1.1K monthly website visits, up 511.1% over the last three months. Biocentis's team grew 25% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed5 investors entered at this stage
Neurone
Global Agri-Food Advancement Partnership
Wellcome Trust
Grantham Foundation
Algebris Investments
Other known investors2 additional known investors
College of Medicine and Integrated Health
Imperial College London
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Biocentis on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Biocentis’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







